Tapinarof Improved Outcomes and Sleep for Patients and Families in Two Phase 3 Atopic Dermatitis Trials in Adults and Children

By sjmartinez • January 9, 2025

Simpson EL, Hebert AA, Browning J, Serrao RT, Sofen H, Brown PM, Piscitelli SC, Rubenstein DS, Tallman AM. Tapinarof Improved Outcomes and Sleep for Patients and Families in Two Phase 3 Atopic Dermatitis Trials in Adults and Children. Dermatol Ther (Heidelb). 2025 Jan 7. doi: 10.1007/s13555-024-01318-6. Epub ahead of print. PMID: 39777610.

Tags: atopic dermatitis, Dermatology, Family impact, Olive View DoM, patient-reported outcomes, Publications, Quality of Life, Sleep improvement, Tapinarof cream 1% once daily, Topical aryl hydrocarbon receptor agonist

Novel Taxol-Derivative, STO-1, Induces Selective Anti-Tumor Immunity and Sustained Remission of Glioblastoma Without Triggering Autoimmune Reactions

Mohapatra S, Guerrero A, Rahman N, Zaman KT, Wu J, Onyeagba C, Hu C, Pellegrini M, Vankudoth J, Kitamura S, O'Donnell L, Wadghiri YZ, Banerjee[...]

Library Preparation for Genome-Wide DNA Methylation Profiling

Hsu FM, Pellegrini M, Chen PY. Library Preparation for Genome-Wide DNA Methylation Profiling. Bio Protoc. 2025 Nov 5;15(21):e5488. doi: 10.21769/BioProtoc.5488. PMID: 41220974; PMCID: PMC12602117.

Cutaneous metastases of alveolar rhabdomyosarcoma in a young adult

Yan MJ, Wongvibulsin S, McKenzie S, Smart CN, Nguyen MO. Cutaneous metastases of alveolar rhabdomyosarcoma in a young adult. JAAD Case Rep. 2025 Sep 26;66:23-25.[...]